96966 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-8
ANTI-NKP30 ANTIBODY AND APPLICATION THEREOF
#2ENHANCED-AFFINITY ANTI-ECM NANOBODY-CYTOKINE FUSIONS AND THEIR APPLICATIONS
#3HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS
#4A FUSION PROTEON OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) AND INTERLEUKIN-2 (IL-2) AND APPLICATIONS THEREOF
#5ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#6METHODS FOR EX VIVO EXPANSION OF NATURAL KILLER CELLS AND USE THEREOF
#7Treatment of infection by human enterovirus D68
#8Humanized antibodies with ultralong complementary determining regions
#9HUMANIZED ANTIBODIES
#10FUNCTION INHIBITOR OF SWI/SNF COMPLEXES
#11Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer
#12TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68
#13CHEMOKINE-CYTOKINE FUSION PROTEINS AND THEIR APPLICATIONS
#14Generating targeted sequence diversity in fusion proteins
#15METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS
#16Glycosaminoglycan-antagonising fusion proteins
#17Kit for immunological detection of TNF-alpha, sTNFR1 and IL-8 in prostate cancer
#18Humanized antibodies
#19Generating targeted sequence diversity in fusion proteins
#20ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#21Class of therapeutic protein based molecules
#22Chemokine-cytokine fusion proteins of SDF-1 and CD40L
#23Treatment of infection by human enterovirus D68
#24Glycosaminoglycan-antagonising fusion proteins and methods of using same
#25Method for inducing ectodermal differentiation of embryoid bodies derived from human pluripotent stem cells by CXCR2 stimulation
#26Substrates and methods for collection, stabilization and elution of biomolecules
#27Class of therapeutic protein based molecules
#28Humanized antibodies with ultralong complementary determining regions
#29Generating targeted sequence diversity in fusion proteins
#30Treatment of acute myeloid leukemia and myelodysplastic syndromes
#31COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#32HUMANIZED ANTIBODIES
#33Class of therapeutic protein based molecules
#34TARGETS AND AGENTS FOR THE TREATMENT OF IMPAIRED BONE FRACTURE HEALING
#35Method for inducing in vivo migration of stem cell
#36Class of therapeutic protein based molecules
#37VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME
#38EXPRESSION MEDIA FOR PROTEINS IN YEAST SYSTEM
#39COMPOSITION FOR TREATMENT OF CXCL8-MEDIATED LUNG INFLAMMATION
#40VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME
#41Chemokine-Chaperone Fusion Proteins
#42USE OF MODIFIED INTERLEUKIN-8 PROTEINS FOR TREATING REPERFUSION INJURY OR TRANSPLANT REJECTION
#43Class of therapeutic protein based molecules
#44GAG BINDING PROTEIN
#45GAG BINDING PROTEINS
#46Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#47Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#48Method of treatment using high-affinity antagonists of ELR-CXC chemokines
#49High-affinity antagonists of ELR-CXC chemokines
#50Leukocyte Adhesion Inhibitor-1 (LAI-1)
#51Novel CXCL8 antagonists
#52GAG binding protein
#53Synthetic approach to designed chemical structures
#54Interleukin-8 Labelled Via One or More Site Specifically Conjugated Hydrazinonicotinamide (Hynic) Moieties and its Use in Diagnosis of Infection and Inflammation
#55GAG binding proteins
#56Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#57N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination
#58Novel il-8-like polypeptides
#59Chemokine analogs for the treatment of human diseases
#60Interleukin-8 homologous polypeptides and therapeutic uses thereof
#61High-affinity antagonists of ELR-CXC chemokines
#62Interleukin-8 homologous polypeptides and therapeutic uses thereof
#63Il-8-like proteins
#64Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
#65Interleukin-8 homologous polypeptides and therapeutic uses thereof
#66Synthetic approach to designed chemical structures
#67Interleukin-8 homologous polypeptides and therapeutic uses thereof
#68Polynucleotides encoding leukocyte adhesion inhibitor-1 (LAI-1)
#69Interleukin-8 homologous polypeptides and therapeutic uses thereof
#70Interleukin-8 homologous polypeptides and therapeutic uses thereof